Hypoxia and the Kynurenine Pathway: Implications and Therapeutic Prospects in Alzheimer’s Disease
Neurodegenerative diseases (NDs) like Alzheimer’s disease, multiple sclerosis, amyotrophic lateral sclerosis, Parkinson’s disease, and Huntington’s disease predominantly pose a significant socioeconomic burden. Characterized by progressive neural dysfunction coupled with motor or intellectual impair...
Guardado en:
Autores principales: | Oluyomi Stephen Adeyemi, Oluwakemi Josephine Awakan, Lawrence Boluwatife Afolabi, Damilare Emmanuel Rotimi, Elizabeth Oluwayemi, Chiagoziem A. Otuechere, Omodele Ibraheem, Tobiloba Chritiana Elebiyo, Omokolade Alejolowo, Afolake T. Arowolo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c1cf4590be2d48c6bd94bdd8bb314c39 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hypoxia-Inducible Factor 1α (HIF1α) Suppresses Virus Replication in Human Cytomegalovirus Infection by Limiting Kynurenine Synthesis
por: Lisa M. Wise, et al.
Publicado: (2021) -
Kynurenine and depressive symptoms in a poststroke population
por: Bensimon K, et al.
Publicado: (2014) -
Electrochemical Determination of Kynurenine Pathway Metabolites—Challenges and Perspectives
por: Ilona Sadok, et al.
Publicado: (2021) -
Serum profiles of tryptophan-kynurenine pathway metabolites in psoriasis
por: Mariko Seishima, et al.
Publicado: (2021) -
Tryptophan, kynurenine pathway, and diabetic ketoacidosis in type 1 diabetes.
por: William H Hoffman, et al.
Publicado: (2021)